Figure 4
From: Plasma apolipopotein C-2 elevation is associated with Takayasu arteritis
(A) The plasma level of apolipoprotein C2 (ApoC-2) is significantly increased in the Takayasu arteritis (TAK) patient group compared with that in the control group (control: N = 16, mean = 82.1 mg/dL; TAK: N = 22, mean = 173.6 mg/dL; P < 0.001). The clinical standard level of ApoC-2 in the plasma is 1.5–3.8 mg/dL for women. (B) The plasma level of apolipoprotein A1 (ApoA-1) shows no significant difference between the TAK patient and control groups (control: N = 16, mean = 67.6 mg/dL; TAK: N = 22, mean = 79.2 mg/dL; P = 0.93). (C)The plasma level of 14–3–3 protein ζ/δ shows no significant difference between the TAK patient and control groups (control: N = 16, mean = 1233.6 pg/mL; TAK: N = 22, mean = 1259.3 pg/mL; P = 0.53). (D) The plasma level of inter-α-trypsin inhibitor heavy chain H4 isoform 1 precursor (ITIH4) shows no significant difference between the TAK patient and control groups (control: N = 16, mean = 35.4 ng/mL; TAK: N = 22, mean = 33.6 ng/mL; P = 0.50).
